Oxaliplatin
Showing 1 - 25 of 2,840
Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)
Not yet recruiting
- Immunotherapy Gastrict Cancer
- Tislelizumab
- +3 more
- (no location specified)
Jan 17, 2023
Gastrointestinal Tumors Trial (Anti-allergic treatment)
Not yet recruiting
- Gastrointestinal Tumors
- Anti-allergic treatment
- (no location specified)
Jun 19, 2023
Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)
Recruiting
- Gastric Cancer
- Apatinib
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023
Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,
Not yet recruiting
- Colorectal Cancer
- HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
- HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
- (no location specified)
Jul 13, 2023
Advanced Gastric Carcinoma Trial in Dhaka (Trastuzumab, Oxaliplatin, Capecitabine)
Completed
- Advanced Gastric Carcinoma
- Trastuzumab
- +2 more
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Aug 15, 2023
Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)
Not yet recruiting
- Neuropathy;Peripheral
- Placebo tablets
- Ketotifen Oral Tablet
-
Tanta, EgyptTanta university
Nov 23, 2022
Chemo Induced Peripheral Neuropathy Trial (Omeprazole)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy
- (no location specified)
Jan 10, 2023
Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)
Recruiting
- Gastric Cancer, Adjuvant Chemotherapy, XO
- Docetaxel and capecitabine and oxaliplatin
- capecitabine and oxaliplatin
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients Trial in Dhaka (lidocaine transdermal patch)
Recruiting
- Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
- lidocaine transdermal patch
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
May 22, 2023
Advanced Colorectal Cancer Trial in Guangzhou
Recruiting
- Advanced Colorectal Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 7, 2023
Stomach Cancer Trial in Seoul (S-1 (452500ACH), OXALIPLATIN (205803BIJ))
Terminated
- Stomach Cancer
- S-1 (452500ACH)
- OXALIPLATIN (205803BIJ)
-
Seoul, Korea, Republic ofKangbuk Samsung Hospital
Dec 6, 2022
First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,
Not yet recruiting
- First-line Treatment of Advanced Pancreatic Cancer
- HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
- nab-paclitaxel; gemcitabine
- (no location specified)
Feb 28, 2023
Colorectal Cancer, Liver Cancer, Gastric Cancer Trial in Créteil, Grenoble, Paris (Acupuncture intervention, No acupuncture)
Not yet recruiting
- Colorectal Cancer
- +4 more
- Acupuncture intervention
- No acupuncture
-
Créteil, France
- +4 more
May 12, 2023
Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)
Recruiting
- Immunotherapy
- Gastrict Cancer
- Tislelizumab
- +3 more
-
Fuzhou, ChinaFujian cancer hospital
Jan 17, 2023
Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent
Completed
- Gastroesophageal Junction Adenocarcinoma
- Oxaliplatin; Capecitabine
- Oxaliplatin; Capecitabine; concurrent radiotherapy
-
Shijiazhuang, Hebei, ChinaDepartment of General Surgery
Feb 4, 2022
Colorectal Cancer, Peripheral Neuropathy Trial (Rood's approach, Traditional physical therapy program)
Not yet recruiting
- Colorectal Cancer
- Peripheral Neuropathy
- Rood's approach
- Traditional physical therapy program
- (no location specified)
May 26, 2023
Malignant Digestive System Tumor Trial in Atlanta (Fluorouracil, Leucovorin, Oxaliplatin)
Recruiting
- Malignant Digestive System Neoplasm
- Fluorouracil
- +2 more
-
Atlanta, Georgia
- +2 more
Dec 12, 2022
Locally Advanced Gastric Carcinoma Trial in Hanzhou (Oxaliplatin by arterial infusion plus S-1, SOX neoadjuvant, gastrectomy
Not yet recruiting
- Locally Advanced Gastric Carcinoma
- Oxaliplatin by arterial infusion plus S-1
- +3 more
-
Hanzhou, Zhejiang, ChinaGastrointestinal Department of Second Affiliated Hospital of Zhe
Oct 20, 2022
Peripheral Neuropathy Trial in Lebanon (Aerobic Exercise)
Active, not recruiting
- Peripheral Neuropathy
- Aerobic Exercise
-
Lebanon, New Hampshire
- +1 more
Jun 13, 2023
Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
- Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 18, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin
Recruiting
- Hepatocellular Carcinoma
- Raltitrexed, oxaliplatin (SALOX) treatment
- Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 17, 2022
Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)
Not yet recruiting
- Gastric Cancer Stage IV
- Oxaliplatin
- +5 more
- (no location specified)
Nov 13, 2022
Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)
Not yet recruiting
- Advanced Colorectal Cancer
- Bevacizumab combined with Oxaliplatin and TAS-102
- (no location specified)
May 16, 2022
Gastric Adenocarcinoma Trial in Beijing (Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1)
Recruiting
- Gastric Adenocarcinoma
- Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 27, 2022